REDUCE-IT
Reduction of Cardiovascular Events with Icosapent Ethyl
Paciente / Población Intervención / Exposición Comparación Desenlace
In 8,179 statin-treated patients with high triglycerides, icosapent ethyl reduced major adverse cardiovascular events compared with placebo.
N
8179
Diseño
Double-blind RCT
Desenlace
CV death, MI, stroke, revascularisation or unstable angina
Relevancia
2
Resultado17.2 % vs 22.0 % (HR 0.75).
Bhatt DL, et al. N Engl J Med. 2019;380(1):11-22. 10.1056/NEJMoa1812792
Discusión y crítica
The mineral-oil placebo raised LDL and CRP, so the true effect is probably smaller than the 25 % reduction. STRENGTH, with a different omega-3, was negative.